Paper33657293
A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
China L and 10 others. N Engl J Med, 2021. Cited by 275 papers, by iCite.
Cite this record
ConductScience Library. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis. Papers, record 33657293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33657293
- Disease
- cirrhosis of liver189 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Albumins | Major topic |
| Liver Cirrhosis | Major topic |
| Serum Albumin | Major topic |
| Adult | |
| Ascites | |
| Female | |
| Hospitalization | |
| Humans | |
| Infusions, Intravenous | |
| Liver Cirrhosis, Alcoholic | |
| Male | |
| Middle Aged | |
| Pulmonary Edema | |
| Treatment Failure |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06483737 | Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE) | Results |
Source ClinicalTrials.gov
Comments and corrections6
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 33657300 | Terlipressin and Intravenous Albumin in Advanced Cirrhosis - Friend and Foe. | https://conductscience.org/library/papers/33657300 | PubMed |
| Comment in | 33753931 | Searching for therapies for advanced cirrhosis. | https://conductscience.org/library/papers/33753931 | PubMed |
| Comment in | 34107190 | Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. | https://conductscience.org/library/papers/34107190 | PubMed |
| Comment in | 34107191 | Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. | https://conductscience.org/library/papers/34107191 | PubMed |
| Comment in | 34107192 | Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. | https://conductscience.org/library/papers/34107192 | PubMed |
| Comment in | 34339226 | In decompensated cirrhosis, targeted albumin infusions did not improve an in-hospital composite outcome at 15 d. | https://conductscience.org/library/papers/34339226 | PubMed |
Cited by165
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 275 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42955590 | Clinical features and associated factors for porto-sinusoidal vascular disease in primary Sjögren's disease: a retrospective cohort study. | Clin Rheumatol | 2026 | https://conductscience.org/library/papers/42955590 | PubMed |
| 42939963 | Albumin Supplementation Preserves Systemic Antioxidant Defenses in Critically Ill, Septic Patients: A Prospective Comparative Study. | Biomedicines | 2026 | https://conductscience.org/library/papers/42939963 | PubMed |
| 42760319 | A randomized, double-blind, active-controlled phase 3 multicenter trial of rHSA for cirrhotic ascites. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42760319 | PubMed |
| 42707863 | Critical care hepatology: A narrative review of current concepts and management. | World J Crit Care Med | 2026 | https://conductscience.org/library/papers/42707863 | PubMed |
| 42581223 | Albumin in the Management of Hepatorenal Syndrome-Acute Kidney Injury: Is There Ever Too Much? | Dig Dis Sci | 2026 | https://conductscience.org/library/papers/42581223 | PubMed |
| 42544300 | Association of nadir serum albumin during hospitalization with mortality in ICU patients with spontaneous intracerebral hemorrhage. | Front Neurol | 2026 | https://conductscience.org/library/papers/42544300 | PubMed |
| 42511757 | Acute-on-Chronic Liver Failure: An Eroded Cliff Hit by a Storm-A Narrative Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511757 | PubMed |
| 42435328 | Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites. | United European Gastroenterol J | 2026 | https://conductscience.org/library/papers/42435328 | PubMed |
| 42384297 | Machine learning phenotypes and heterogeneous albumin effects in cirrhotic AKI: a causal inference study. | Intern Emerg Med | 2026 | https://conductscience.org/library/papers/42384297 | PubMed |
| 42347089 | Association of Early Albumin Administration with Clinical Outcomes in Patients Hospitalized with Spontaneous Bacterial Peritonitis: A Propensity-Matched Cohort Study. | Reports (MDPI) | 2026 | https://conductscience.org/library/papers/42347089 | PubMed |
| 42292189 | Association between baseline-stratified trajectory subgroups of serum albumin and outcomes in critically ill patients with early sepsis-associated acute kidney injury: a retrospective study. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42292189 | PubMed |
| 42194556 | Factors Associated with Short-Term Clinical Outcomes in ICU Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia: A Single-Center Retrospective Cohort Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/42194556 | PubMed |
| 42007477 | Exploring the prognostic value of serum albumin in critically ill cancer patients: an observational cohort study utilizing machine learning from large intensive care unit databases. | JAMIA Open | 2026 | https://conductscience.org/library/papers/42007477 | PubMed |
| 42007297 | Neutrophil Percentage-to-Albumin Ratio as a Predictor of Urinary Tract Infection in Patients with Urinary Stone Disease: Development a Novel User-Friendly Tool. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42007297 | PubMed |
| 41940988 | Hypoalbuminemia induces immunosuppression through disorder in macrophages and drives resistance to immune checkpoint inhibitors. | Cancer Immunol Immunother | 2026 | https://conductscience.org/library/papers/41940988 | PubMed |
| 41908587 | Pathogen-Specific Hypoalbuminemia in Patients with Sepsis: A Retrospective Study with Propensity Score Analysis. | Infect Drug Resist | 2026 | https://conductscience.org/library/papers/41908587 | PubMed |
| 41889150 | Low-Dose vs. Standard Care Iv Human Albumin During Large-Volume Paracentesis in Patients With Liver Cirrhosis: A Systematic Review. | Liver Int | 2026 | https://conductscience.org/library/papers/41889150 | PubMed |
| 41827398 | Use of Human Serum Albumin in Critically Ill Patients: A Narrative Review. | J Clin Med | 2026 | https://conductscience.org/library/papers/41827398 | PubMed |
| 41753205 | Nonselective Beta Blockers Are Beneficial in Patients with Cirrhotic Ascites and Spontaneous Bacterial Peritonitis: A Propensity-Matched Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41753205 | PubMed |
| 41733828 | Not Just for Volume Anymore: New Indications for Albumin in Patients with Liver Disease. | Dig Dis Sci | 2026 | https://conductscience.org/library/papers/41733828 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Drugs4
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| ALBUMIN HUMAN | CHEMBL1201451 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1201451 | ChEMBL |
| ARGININE | CHEMBL1485 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1485 | ChEMBL |
| RIFAXIMIN | CHEMBL1617 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1617 | ChEMBL |
| LACTULOSE | CHEMBL296306 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL296306 | ChEMBL |
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33657293
GET https://conductscience.org/api/papers/v1/33657293/cited_by?page=2